Download full-text PDF

Source

Publication Analysis

Top Keywords

[lyophilized smallpox
4
smallpox vaccine
4
vaccine immunologic
4
immunologic response
4
response clinical
4
clinical observations]
4
[lyophilized
1
vaccine
1
immunologic
1
response
1

Similar Publications

Modified Vaccinia Ankara Bavarian Nordic (MVA-BN) as a smallpox and mpox vaccine has been approved in its liquid-frozen (LF) formulation in the US, Canada, and EU. A freeze-dried (FD) formulation may offer additional benefits, such as a longer shelf life and reduced dependence on cold chain storage and transport. In a phase 2 clinical trial, 651 vaccinia-naïve participants were vaccinated with two doses of MVA-BN LF or FD, 4 weeks apart.

View Article and Find Full Text PDF

Vaccinia virus-based vaccines confer protective immunity against SARS-CoV-2 virus in Syrian hamsters.

PLoS One

September 2021

Molecular and Cell Biology, Taiwan International Graduate Program, National Defense Medical Center, Academia Sinica and Graduate Institute of Life Science, Taipei, Taiwan.

COVID-19 in humans is caused by Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) that belongs to the beta family of coronaviruses. SARS-CoV-2 causes severe respiratory illness in 10-15% of infected individuals and mortality in 2-3%. Vaccines are urgently needed to prevent infection and to contain viral spread.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the immunological responses to the modified vaccinia Ankara (MVA) smallpox vaccine using 523 participants who received either lyophilized or liquid MVA in different administration methods.
  • Results showed that MVA triggered significant antibody production against several viral proteins, particularly after 28 and 42 days, with strong correlations between some antibody responses and plaque reduction neutralization tests (PRNT).
  • The findings suggest that specific proteins from the MVA vaccine could be potential indicators of protection and may inform future vaccine development strategies.
View Article and Find Full Text PDF

Chronicle of a consolidated success: smallpox eradication policies in Brazil (1962-1973).

Salud Colect

August 2019

Estudiante de Doctorado, Programa de Pós-Graduación en Ciências Sociais, Instituto de Filosofia y Ciências Humanas, Universidade Estadual de Campinas, San Pablo, Brasil.

The aim of this article is to understand actions taken towards smallpox eradication in Brazil, in the framework of the Smallpox Eradication campaign that took place in the 1960s and 1970s. The article argues that, in addition to the bifurcated needle and the lyophilized vaccine, epidemiological surveillance - based on the construction of instruments and protocols for health surveillance - was the third key element that guaranteed the eradication of the disease. The hypothesis is that the actions taken towards the control and eradication of smallpox contributed to the construction of new health institutions within Brazil.

View Article and Find Full Text PDF

Background: In Japan, production of smallpox vaccine LC16m8 (named LC16-KAKETSUKEN) was restarted and was determined to be maintained as a national stockpile in March 2002.

Objective: To conduct a post-marketing surveillance study of the vaccination of freeze-dried live attenuated smallpox vaccine prepared in cell culture LC16-KAKETSUKEN using attenuated vaccinia strain LC16m8. The study complied with Good Clinical Practice, focusing on a comparison between primary vaccinees and re-vaccinees.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!